A detailed history of Washington Trust CO transactions in Organon & Co. stock. As of the latest transaction made, Washington Trust CO holds 1,192 shares of OGN stock, worth $18,213. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,192
Previous 1,192 -0.0%
Holding current value
$18,213
Previous $24,000 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$13.78 - $18.8 $55 - $75
-4 Reduced 0.33%
1,192 $22,000
Q4 2023

Jan 18, 2024

SELL
$10.95 - $17.32 $120 - $190
-11 Reduced 0.91%
1,196 $17,000
Q3 2023

Oct 18, 2023

SELL
$16.59 - $23.77 $2,322 - $3,327
-140 Reduced 10.39%
1,207 $20,000
Q2 2023

Jul 27, 2023

SELL
$19.27 - $24.63 $4,085 - $5,221
-212 Reduced 13.6%
1,347 $28,000
Q1 2023

May 10, 2023

BUY
$21.42 - $32.08 $33,115 - $49,595
1,546 Added 154600.0%
1,547 $36,000
Q1 2023

May 04, 2023

SELL
$21.42 - $32.08 $33,372 - $49,980
-1,558 Reduced 99.94%
1 $36,000
Q4 2022

Jul 27, 2023

BUY
$23.31 - $28.61 $279 - $343
12 Added 0.78%
1,559 $43,000
Q4 2022

Feb 08, 2023

SELL
$23.31 - $28.61 $652 - $801
-28 Reduced 1.76%
1,559 $44,000
Q3 2022

Oct 14, 2022

SELL
$23.4 - $34.25 $772 - $1,130
-33 Reduced 2.04%
1,587 $37,000
Q2 2022

Jul 25, 2022

SELL
$31.66 - $38.9 $2,437 - $2,995
-77 Reduced 4.54%
1,620 $55,000
Q1 2022

May 05, 2022

BUY
$30.45 - $39.36 $913 - $1,180
30 Added 1.8%
1,697 $60,000
Q4 2021

Feb 09, 2022

SELL
$28.67 - $37.13 $34,547 - $44,741
-1,205 Reduced 41.96%
1,667 $51,000
Q3 2021

Nov 09, 2021

BUY
$28.63 - $35.64 $73,550 - $91,559
2,569 Added 847.85%
2,872 $94,000
Q2 2021

Aug 05, 2021

BUY
$28.45 - $38.0 $8,620 - $11,514
303 New
303 $9,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Washington Trust CO Portfolio

Follow Washington Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.